• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名感染1型人类免疫缺陷病毒(HTLV-III B型)的实验室工作人员的病毒变异性和血清抗体反应

Viral variability and serum antibody response in a laboratory worker infected with HIV type 1 (HTLV type IIIB).

作者信息

Reitz M S, Hall L, Robert-Guroff M, Lautenberger J, Hahn B M, Shaw G M, Kong L I, Weiss S H, Waters D, Gallo R C

机构信息

Laboratory of Tumor Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892.

出版信息

AIDS Res Hum Retroviruses. 1994 Sep;10(9):1143-55. doi: 10.1089/aid.1994.10.1143.

DOI:10.1089/aid.1994.10.1143
PMID:7826699
Abstract

Molecular clones of HIV-1 were obtained from isolates cultured from peripheral blood mononuclear cells (PBMCs) and directly from uncultured PBMCs from a laboratory worker accidentally infected with the HIV-1 laboratory strain, HIV-1(HTLV-IIIB). Envelope sequences corresponding to the first 752 amino acids of HIV-1(HTLV-IIIB) clone BH10 were obtained from clones of cultured virus and sequenced. Three env clones obtained shortly after infection differed among themselves at only seven nucleotide positions, resulting in one amino acid substitution and one frameshift mutation. These envelope sequences were as similar to the envelope sequences of various IIIB clones as the latter were to each other. env divergence increased over the course of infection. However, the overall diversity in env clones obtained two or more years after infection was still comparable to that among IIIB env clones from the original IIIB culture. Multiple clones of partial env gene sequences containing the V3 loop were also obtained directly from uncultured PBMCs by polymerase chain reaction amplification. The env sequences of these clones were generally similar to those of the cultured viruses. Within the V3 region, the earliest isolates retained the sequence of the HXB2 clone from IIIB. Clones obtained later showed a progressive divergence in V3. An A-to-T substitution within the GPGRAF sequence at the tip of the V3 loop was observed within 1 year after infection, and this mutation predominated in all subsequent isolates. Antibodies against the V3 loops of IIIB and divergent 1987 and 1990 LW isolates appeared simultaneously in laboratory worker serum and persisted with no significant differences in titer. Furthermore, neutralization studies with autologous sequential sera suggested selection for the A-to-T change in V3 was not due to V3-directed antibodies. These results demonstrate a surprising homogeneity among env sequences of HIV-1 from an infected laboratory worker, perhaps because the initial infection originated from a relatively homogeneous population of tissue culture-adapted virus.

摘要

HIV-1分子克隆是从外周血单核细胞(PBMC)培养的分离株中获得的,也直接从一名意外感染HIV-1实验室毒株HIV-1(HTLV-IIIB)的实验室工作人员的未培养PBMC中获得。从培养病毒的克隆中获取了与HIV-1(HTLV-IIIB)克隆BH10的前752个氨基酸相对应的包膜序列并进行测序。感染后不久获得的三个env克隆彼此之间仅在七个核苷酸位置存在差异,导致一个氨基酸替换和一个移码突变。这些包膜序列与各种IIIB克隆的包膜序列相似程度,与后者之间的相似程度相同。env差异在感染过程中增加。然而,感染两年或更长时间后获得的env克隆的总体多样性仍与原始IIIB培养物中IIIB env克隆之间的多样性相当。还通过聚合酶链反应扩增直接从未培养的PBMC中获得了多个包含V3环的部分env基因序列克隆。这些克隆的env序列通常与培养病毒的env序列相似。在V3区域内,最早的分离株保留了来自IIIB的HXB2克隆的序列。后来获得的克隆在V3区域显示出逐渐的差异。在感染后1年内观察到V3环顶端的GPGRAF序列内发生了A到T的替换,并且该突变在所有后续分离株中占主导地位。针对IIIB以及1987年和1990年不同的LW分离株的V3环的抗体同时出现在实验室工作人员血清中,并且效价没有显著差异地持续存在。此外,用自体连续血清进行的中和研究表明,V3中A到T变化的选择不是由于V3导向的抗体。这些结果表明,来自一名受感染实验室工作人员的HIV-1的env序列之间存在惊人的同质性,这可能是因为最初的感染源自相对同质的组织培养适应病毒群体。

相似文献

1
Viral variability and serum antibody response in a laboratory worker infected with HIV type 1 (HTLV type IIIB).一名感染1型人类免疫缺陷病毒(HTLV-III B型)的实验室工作人员的病毒变异性和血清抗体反应
AIDS Res Hum Retroviruses. 1994 Sep;10(9):1143-55. doi: 10.1089/aid.1994.10.1143.
2
Envelope sequence variability and serologic characterization of HIV type 1 group O isolates from equatorial guinea.赤道几内亚1型O组HIV分离株的包膜序列变异性和血清学特征
AIDS Res Hum Retroviruses. 1997 Aug 10;13(12):995-1005. doi: 10.1089/aid.1997.13.995.
3
Presence of multiple genetic subtypes of human immunodeficiency virus type 1 proviruses in Uganda.乌干达存在1型人类免疫缺陷病毒前病毒的多种基因亚型。
AIDS Res Hum Retroviruses. 1994 Nov;10(11):1543-50. doi: 10.1089/aid.1994.10.1543.
4
Subgroup G HIV type 1 isolates from Nigeria.来自尼日利亚的G亚组1型艾滋病毒分离株。
AIDS Res Hum Retroviruses. 1994 Nov;10(11):1581-3. doi: 10.1089/aid.1994.10.1581.
5
Insertion of primary syncytium-inducing (SI) and non-SI envelope V3 loops in human immunodeficiency virus type 1 (HIV-1) LAI reduces neutralization sensitivity to autologous, but not heterologous, HIV-1 antibodies.将1型人类免疫缺陷病毒(HIV-1)LAI的主要合胞体诱导(SI)和非SI包膜V3环插入后,会降低其对自身HIV-1抗体的中和敏感性,但不会降低对异源HIV-1抗体的中和敏感性。
J Virol. 1995 Oct;69(10):6342-51. doi: 10.1128/JVI.69.10.6342-6351.1995.
6
Identification of HIV-1 determinants for replication in vivo.鉴定HIV-1在体内复制的决定因素。
Virology. 1997 Jan 6;227(1):45-52. doi: 10.1006/viro.1996.8338.
7
[Biological characteristics of HIV-1 isolates circulating in China are linked to its env V3 loop sequence variability].[中国流行的HIV-1分离株的生物学特性与其env V3环序列变异性有关]
Zhonghua Yi Xue Za Zhi. 2004 Dec 2;84(23):1968-72.
8
Molecular analyses of HIV-1 group O and HIV-2 variants from Africa.来自非洲的HIV-1 O组和HIV-2变体的分子分析。
Leukemia. 1997 Apr;11 Suppl 3:138-41.
9
Genetic diversity of human immunodeficiency virus type 1 strains in Kinshasa, Zaire.扎伊尔金沙萨人类免疫缺陷病毒1型毒株的基因多样性。
AIDS Res Hum Retroviruses. 1993 Jul;9(7):613-8. doi: 10.1089/aid.1993.9.613.
10
Evidence for rapid selection and deletion of HIV-1 subpopulations in vivo by V3-specific neutralizing antibody: a model of humoral-associated selection.V3特异性中和抗体在体内对HIV-1亚群进行快速选择和清除的证据:一种体液相关选择模型
Dev Biol Stand. 1990;72:315-41.

引用本文的文献

1
Pathogenesis of HTLV-1 infection and progression biomarkers: An overview.HTLV-1 感染和进展生物标志物的发病机制:概述。
Braz J Infect Dis. 2021 May-Jun;25(3):101594. doi: 10.1016/j.bjid.2021.101594. Epub 2021 Jul 10.
2
Differential glycosylation of envelope gp120 is associated with differential recognition of HIV-1 by virus-specific antibodies and cell infection.包膜 gp120 的差异糖基化与病毒特异性抗体对 HIV-1 的不同识别和细胞感染有关。
AIDS Res Ther. 2014 Aug 1;11:23. doi: 10.1186/1742-6405-11-23. eCollection 2014.
3
Polar profile of antiviral peptides from AVPpred Database.
来自AVPpred数据库的抗病毒肽的极性分布图。
Cell Biochem Biophys. 2014 Nov;70(2):1469-77. doi: 10.1007/s12013-014-0084-4.
4
The 20S proteasome splicing activity discovered by SpliceMet.由 SpliceMet 发现的 20S 蛋白酶体剪接活性。
PLoS Comput Biol. 2010 Jun 24;6(6):e1000830. doi: 10.1371/journal.pcbi.1000830.
5
Glycosylation patterns of HIV-1 gp120 depend on the type of expressing cells and affect antibody recognition.HIV-1 gp120 的糖基化模式取决于表达细胞的类型,并影响抗体的识别。
J Biol Chem. 2010 Jul 2;285(27):20860-9. doi: 10.1074/jbc.M109.085472. Epub 2010 May 3.
6
HIV-1 Vpr: mechanisms of G2 arrest and apoptosis.人类免疫缺陷病毒1型病毒蛋白R(HIV-1 Vpr):G2期阻滞和细胞凋亡机制
Exp Mol Pathol. 2008 Aug;85(1):2-10. doi: 10.1016/j.yexmp.2008.03.015. Epub 2008 Apr 25.
7
Human immunodeficiency virus type 1 Vpr links proteasomal degradation and checkpoint activation.1型人类免疫缺陷病毒Vpr将蛋白酶体降解与检查点激活联系起来。
J Virol. 2008 Feb;82(3):1066-72. doi: 10.1128/JVI.01628-07. Epub 2007 Sep 12.
8
Increased sensitivity to CD4 binding site-directed neutralization following in vitro propagation on primary lymphocytes of a neutralization-resistant human immunodeficiency virus IIIB strain isolated from an accidentally infected laboratory worker.从一名意外感染的实验室工作人员分离出的中和抗性人类免疫缺陷病毒IIIB株在原代淋巴细胞上进行体外增殖后,对CD4结合位点定向中和的敏感性增加。
J Virol. 2004 Jun;78(11):5651-7. doi: 10.1128/JVI.78.11.5651-5657.2004.
9
HIV-1 replication and pathogenesis in the human thymus.HIV-1在人类胸腺中的复制与发病机制。
Curr HIV Res. 2003 Jul;1(3):275-85. doi: 10.2174/1570162033485258.
10
Human immunodeficiency virus type 1 IIIB selected for replication in vivo exhibits increased envelope glycoproteins in virions without alteration in coreceptor usage: separation of in vivo replication from macrophage tropism.在体内选择进行复制的1型人类免疫缺陷病毒IIIB在病毒粒子中包膜糖蛋白增加,但共受体使用情况未改变:体内复制与巨噬细胞嗜性的分离。
J Virol. 2001 Sep;75(18):8498-506. doi: 10.1128/jvi.75.18.8498-8506.2001.